Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

 

Finance 150x110First Quarter 2017 Financial Results

Genmab will report its First Quarter 2017 financial results after market close on May 10. An investor conference call to discuss the results will be held at 6PM CEST / 12PM EDT on May 10. To join the call by phone, dial one of the following numbers and ask for the Genmab conference call:  +4532 71 16 59 in Denmark, +44 20 3427 1910 in the UK or +1212 444 0896 in the US. Click here to listen to the webcast. 

film thumnail croppedEmployee Film Featured at Annual General Meeting

Take a look behind the scenes in a video describing the important role teamwork and Genmab employees play in the company's success. Click here to watch. 

Join our teamCareer Opportunities at Genmab

Genmab is seeking new employees to join our teams in Copenhagen, Utrecht and Princeton.  Visit our Careers webpages to explore our current vacancies, learn about our culture and meet some of our team members.